Benjamin Bruneau

Chief Financial Officer at genOway

Benjamin Bruneau started their work experience in 2003 as a Financial Auditor at Ernst & Young, where they handled auditorship missions for companies in various industries. In 2005, they joined Solvay as a Lead Internal Auditor, conducting operational and financial reviews of industrial sites and managing audit assignments. In 2007, they became the Financial Corporate Controller, responsible for forecasting and reporting the earnings of Rhodia Services. Benjamin then moved on to the role of Manager Investor Relation, where they prepared financial and operational presentations for financial markets and informed the management team about market perceptions. In 2011, they became the Global Market Financial Analyst at Novecare business unit and later took on the role of Europe Finance Director. In 2015, they became the Chief Financial Officer at genOway.

Benjamin Bruneau pursued their education at AgroParisTech from 2001 to 2003, where they obtained an Engineering degree with a specialization in Economics and Marketing. Prior to that, from 1996 to 2001, they studied Biochemistry with a specialization in biotechnologies at Université des Sciences Paul Sabatier Toulouse and earned a Master's degree.

Location

Lyon, France

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


genOway

1 followers

Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.


Industries

Headquarters

Lyon, France

Employees

51-200

Links